Abstract
We present serial MR perfusion and spectroscopic findings of a pathologically proved low grade glioma, which evolved into glioblastoma multiforme in 2 years in a 24-year-old man. The initial MR imaging studies, including enhanced conventional T1-weighted and perfusion imaging, were characteristic of a benign glioma with the only exception being that multi-voxel proton MR spectroscopy showed malignant features with a high choline:phosphocreatine ratio. Postoperative follow-up MR imaging revealed findings consistent with malignant glioma, with increased angiogenesis on perfusion images and heterogeneous enhancement on contrast-enhanced T1-weighted images that were further confirmed by second surgery. We suggest conducting close MR imaging follow-up of patients with glioma who have discrepant MR spectroscopic and perfusion results after treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 1775-1778 |
| Number of pages | 4 |
| Journal | American Journal of Neuroradiology |
| Volume | 23 |
| Issue number | 10 |
| Publication status | Published - Nov 2002 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Clinical Neurology
- Radiology Nuclear Medicine and imaging
Fingerprint
Dive into the research topics of 'Discrepant MR spectroscopic and perfusion imaging results in a case of malignant transformation of cerebral glioma'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS